Immune System Blood Tests: WBC, Immunoglobulins & Autoimmune Markers
Your immune system is extraordinarily complex, but blood tests can reveal when it's underperforming, overreacting, or attacking your own tissues. Here's what each test actually measures and when it's worth ordering.
What "Boosting Your Immune System" Actually Means (Not Much)
The concept of "boosting" the immune system is one of the most profitable myths in health marketing. Your immune system is not a single entity that can be turned up like a volume dial. It is a complex network of dozens of cell types, hundreds of signalling molecules, and multiple organ systems working in carefully regulated balance.
An Overactive Immune System Is Dangerous
Autoimmune diseases (lupus, rheumatoid arthritis, type 1 diabetes) are caused by an immune system that is too active, attacking the body’s own tissues. Allergies and anaphylaxis are immune overreactions to harmless substances. You do not want a "boosted" immune system — you want a well-regulated one.
What Actually Supports Immune Function
Adequate sleep (7–9 hours), regular exercise, not smoking, moderate alcohol intake, a varied diet with adequate vitamins D and C, stress management, and up-to-date vaccinations. These do not "boost" immunity — they prevent the immune suppression caused by poor lifestyle habits. No supplement has been proven to enhance immune function in well-nourished individuals.
Key Immune System Blood Tests
White Blood Cell (WBC) Differential
What it measures: The WBC differential is the cornerstone of immune system assessment. It breaks down the total white blood cell count into five cell types, each with distinct roles. Neutrophils are the first responders to bacterial infection. Lymphocytes (B-cells and T-cells) drive adaptive immunity and viral defence. Monocytes are scavengers that clean up debris and present antigens. Eosinophils respond to parasites and allergic reactions. Basophils release histamine and play a role in allergic inflammation. The pattern of which cells are elevated or depleted tells your GP what type of immune challenge your body is facing.
Normal ranges: Total WBC: 4.0–11.0 ×10⁹/L. Neutrophils: 2.0–7.5 ×10⁹/L (40–70%). Lymphocytes: 1.0–4.0 ×10⁹/L (20–40%). Monocytes: 0.2–1.0 ×10⁹/L (2–10%). Eosinophils: 0.04–0.4 ×10⁹/L (1–6%). Basophils: 0.01–0.1 ×10⁹/L (<1%).
Elevated in: Neutrophilia: bacterial infection, inflammation, stress, corticosteroids. Lymphocytosis: viral infections (EBV, CMV, hepatitis), chronic lymphocytic leukaemia. Monocytosis: chronic infections (TB), autoimmune disease, recovery from acute infection. Eosinophilia: allergies, asthma, parasites, drug reactions, eosinophilic oesophagitis. Basophilia: myeloproliferative disorders (rare).
Limitations: WBC can be normal in localised infections and in immunocompromised patients. Some healthy individuals have constitutionally low neutrophil counts (benign ethnic neutropenia) — common in people of African, Middle Eastern, and some Indigenous Australian ancestry. This is a normal variant, not immunodeficiency. Steroids and stress elevate WBC without infection. Recent exercise can cause transient leukocytosis.
Immunoglobulins (IgG, IgA, IgM, IgE)
What it measures: Immunoglobulins (antibodies) are proteins produced by B-lymphocytes that recognise and neutralise specific pathogens. IgG is the most abundant antibody (75% of total), providing long-term immunity and crossing the placenta to protect newborns. IgA guards mucosal surfaces (gut, respiratory tract, urinary tract). IgM is the first antibody produced in response to a new infection (indicates acute infection). IgE mediates allergic reactions and parasitic defence. Testing immunoglobulin levels helps diagnose primary immunodeficiency, myeloma, and chronic infections.
Normal ranges: IgG: 7.0–16.0 g/L. IgA: 0.7–4.0 g/L. IgM: 0.4–2.3 g/L (males), 0.4–2.8 g/L (females). IgE: below 120 kU/L (adults). IgG subclasses: IgG1 (60–70%), IgG2 (14–20%), IgG3 (4–8%), IgG4 (1–4%). Ranges are age-dependent in children.
Elevated in: IgG elevated: chronic infections, autoimmune disease, liver disease, multiple myeloma (monoclonal spike). IgA elevated: liver disease (especially alcoholic), IgA nephropathy, chronic mucosal infections. IgM elevated: acute infection, Waldenström’s macroglobulinaemia, primary biliary cholangitis. IgE elevated: allergic disease, parasitic infections, atopic dermatitis, allergic bronchopulmonary aspergillosis.
Limitations: Low immunoglobulins can be primary (genetic immunodeficiency, such as common variable immunodeficiency or selective IgA deficiency) or secondary (caused by medications, protein-losing conditions, or lymphoproliferative disorders). Selective IgA deficiency affects approximately 1 in 500 Australians and is often asymptomatic. Total IgG does not reveal whether specific pathogen antibodies are present — specific serology is needed for that.
Complement System (C3 and C4)
What it measures: The complement system is a cascade of proteins that enhances the ability of antibodies to clear pathogens, promote inflammation, and attack cell membranes. C3 and C4 are the most commonly measured complement components. Low complement levels indicate consumption (the complement is being "used up" fighting immune complexes or inflammation). C3 and C4 are particularly important in monitoring systemic lupus erythematosus (SLE), where complement consumption correlates with disease activity.
Normal ranges: C3: 0.9–1.8 g/L. C4: 0.1–0.4 g/L. CH50 (total haemolytic complement): varies by assay. Low C3 and C4 together suggest immune complex consumption (SLE, post-infectious glomerulonephritis). Low C4 alone suggests hereditary angioedema (C1 esterase inhibitor deficiency) or cryoglobulinaemia.
Elevated in: Elevated C3 and C4: acute-phase response (inflammation, infection). They are positive acute-phase reactants, so levels may be normal or high even during disease flares if there is concurrent acute infection. Persistently normal complement during suspected SLE flare makes the diagnosis less likely.
Limitations: Complement levels alone do not diagnose any condition — they must be interpreted with clinical features, ANA, and other autoimmune markers. Hereditary complement deficiencies are rare but important: they predispose to meningococcal infections and SLE. CH50 measures the functional integrity of the entire classical pathway but is not widely available in all Australian labs.
Autoimmune Markers (ANA, RF, Anti-CCP)
What it measures: Autoimmune markers detect antibodies directed against the body’s own tissues. ANA (antinuclear antibody) is the most commonly ordered screening test for autoimmune disease. A positive ANA suggests the immune system is producing antibodies against nuclear components, but it is NOT specific for any single disease. RF (rheumatoid factor) and anti-CCP (anti-cyclic citrullinated peptide) are used to diagnose rheumatoid arthritis. ENA (extractable nuclear antigen) panel and anti-dsDNA help subtype SLE and other connective tissue diseases.
Normal ranges: ANA: negative at 1:40 dilution is normal. Low-titre positive (1:40–1:80) occurs in 10–15% of healthy people. Significant titres are typically 1:160 or above. RF: below 14 IU/mL. Anti-CCP: below 5 U/mL (highly specific for RA, 97%). Anti-dsDNA: negative or below lab threshold (specific for SLE).
Elevated in: ANA positive: SLE (95%), drug-induced lupus, Sjögren’s, scleroderma, polymyositis, but also in 10–15% of healthy individuals (especially elderly women). RF positive: RA (70–80%), Sjögren’s, hepatitis C, chronic infections, and 5–10% of healthy elderly. Anti-CCP positive: RA (highly specific), occasionally positive years before RA symptoms develop. Anti-dsDNA positive: active SLE (highly specific, levels correlate with disease activity).
Limitations: The biggest pitfall in autoimmune testing is ordering ANA without a clinical reason. A positive ANA in someone without symptoms is almost always a false positive and leads to anxiety and unnecessary specialist referrals. The RACGP recommends ANA testing ONLY when clinical features suggest autoimmune disease (joint pain, rash, Raynaud’s, dry eyes/mouth, unexplained organ involvement). ANA should never be used as a screening test in asymptomatic individuals.
When Your GP Orders Immune Tests: Common Scenarios
Immune testing is guided by symptoms, not ordered routinely. Here are the most common clinical scenarios and what your GP or specialist will investigate:
| Scenario | Tests Ordered | Looking For |
|---|---|---|
| Recurrent infections (>4 sinusitis/year, >2 pneumonias, recurrent skin abscesses) | FBC + differential, immunoglobulins (IgG, IgA, IgM), IgG subclasses, complement (C3, C4) | Primary immunodeficiency (CVID, IgA deficiency), neutropenia, complement deficiency |
| Joint pain + fatigue + rash (possible autoimmune) | ANA, ENA panel, anti-dsDNA, RF, anti-CCP, C3, C4, FBC, ESR, CRP | SLE, RA, Sjögren’s, mixed connective tissue disease |
| Unexplained eosinophilia on FBC | Parasite serology, IgE, stool microscopy, chest X-ray, tryptase | Parasitic infection, allergic disease, eosinophilic disorders, haematological malignancy |
| Unexplained lymphadenopathy (swollen glands) | FBC + film, LDH, serology (EBV, CMV, HIV, toxoplasmosis), immunoglobulins, flow cytometry | Viral infection, lymphoma, chronic lymphocytic leukaemia, sarcoidosis |
| Suspected allergy (hives, anaphylaxis, eczema) | Total IgE, specific IgE (RAST) for suspected allergens, tryptase (if anaphylaxis suspected) | Specific allergen triggers, mastocytosis (if tryptase persistently elevated) |
| HIV risk assessment or routine screening | 4th generation HIV Ag/Ab combo test (detects both antibody and p24 antigen) | HIV infection (window period: 2–6 weeks for 4th gen test, virtually 100% sensitive by 6 weeks) |
HIV Testing in Australia
HIV testing is an important part of immune system assessment and sexual health screening. Modern 4th generation tests detect both HIV antibodies AND p24 antigen, reducing the window period to approximately 2\u20136 weeks after exposure (virtually 100% sensitive by 6 weeks). Testing is confidential, bulk billed by Medicare, and available from your GP, sexual health clinics, and some community organisations.
All adults should have at least one HIV test in their lifetime (ASHM recommendation)
Annual testing for men who have sex with men and other higher-risk groups
Testing is recommended in pregnancy (routine antenatal screening)
Rapid point-of-care tests are available at sexual health clinics (result in 20 minutes)
A reactive (positive) rapid test ALWAYS requires confirmatory lab testing
PrEP users should be tested every 3 months
CD4 count and viral load are monitored AFTER diagnosis, not for screening
Post-exposure prophylaxis (PEP) should start within 72 hours of potential exposure
Related Reading
Track Your Immune Markers Over Time
Upload your blood test results and our AI will graph your white blood cells, immunoglobulins, and inflammatory markers. Spot trends in your immune function — free and private.
Reference ranges sourced from the Royal College of Pathologists of Australasia (RCPA). HIV testing guidance from the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM). SmarterBlood provides health information and AI-powered blood test analysis. It is not a substitute for professional medical advice, diagnosis, or treatment.